Paul Sagan | Investor Relations |
Glenn Mattes | President, Chief Executive Officer and Director |
Dale Christensen | Director-Clinical Development |
Kirk Coleman | Chief Financial Officer |
Bill Williams | Professor, University of Texas, Austin |
Chris Cano | Chief Operating Officer and Head-Business Development |
Jonathan Aschoff | ROTH Capital Partners |
Daniel Carlson | TW Research Group |
Ram Selvaraju | H.C. Wainwright |
Bill Morrison | National Securities |
Thank you for standing by. Welcome the TFF Pharmaceuticals Inc.
First Quarter 2021 Financial and Business Results Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions] Now I like to introduce your host for today’s program Paul Sagan, Investor Relations.